Raia Drogasil (OTCMKTS:RADLY) Stock Price Down 9.7% – Time to Sell?

Shares of Raia Drogasil S.A. (OTCMKTS:RADLYGet Free Report) traded down 9.7% on Tuesday . The company traded as low as $3.47 and last traded at $3.5214. 858 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 69,451 shares. The stock had previously closed at $3.90.

Raia Drogasil Stock Performance

The business has a fifty day moving average of $3.57 and a 200 day moving average of $4.21.

Raia Drogasil (OTCMKTS:RADLYGet Free Report) last released its quarterly earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share for the quarter, meeting the consensus estimate of $0.05. The company had revenue of $2.17 billion during the quarter, compared to the consensus estimate of $2.32 billion. On average, research analysts expect that Raia Drogasil S.A. will post 0.16 EPS for the current year.

About Raia Drogasil

(Get Free Report)

Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.

The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.

Recommended Stories

Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.